- This event has passed.
ASHG Annual Meeting
11/01/2023 - 11/05/2023
Connect with Seer at the ASHG Annual Meeting
Booth #612
November 1-5, 2023 | Washington, DC
Seer is looking forward to meeting with the world’s best and brightest in human genetics and genomics research as they convene once a year for the ASHG Annual Meeting! Along with the more than 8,000 scientists from around the globe at ASHG 2023 to participate in a 5-day program comprising the year’s most significant new advances in the field. Seer is excited to learn more about your projects and proteogenomics research.
Meet our team at booth #612
Attend our CoLab Session:
Thursday, November 2
3:00 PM – 3:30 PM
CoLab Theater #3
Thinking Beyond Validation: Why Proteomics Provides Unique Insights into Translational Research
Join Jon Brudvig, Ph.D. and Serafim Batzoglou, Ph.D., as they share the research introducing a novel data analysis method that not only enhances pQTL analysis by accounting for protein-altering variants but also underscores the limitations of affinity-based approaches, revealing clinically relevant protein variants often overlooked by these methods.
Featured Speakers
Jon Brudvig, Ph.D.
Director, Discovery Research & Gene Therapy, Amicus Therapeutics
Serafim Batzoglou, Ph.D.
Chief Data Officer, Seer, Inc.
Posters featuring Seer Technology
Thursday, November 2
Characterization of optimal protein quantification strategies for sensitive pQTL analyses in human blood plasma samples.
Presented by G. Venkataraman, Seer Inc.
Board No. PB3337 | Omics Technologies Poster Session I, 3pm – 5pm
Temporal landscape of the Alzheimer’s Disease plasma proteome: an 1800-sample cohort study.
Presented by A. Siddiqui, Seer Inc.
Board No. PB1798 | Complex Traits and Polygenic Disorders Poster Session I, 3pm – 5pm
Friday, November 3
Utilizing targeted TSO500 ctDNA NGS assay and Seer Proteograph to study genome and proteome changes in various cancer types
Presented by N. Prasad, Discovery Life Sciences
Board No. PB4571 | Genetic, Genomic, and Epigenomic Resources and Databases Poster Session II, 3pm – 5pm
Saturday, November 4
Nanoparticle enrichment mass-spectrometry proteomics identifies protein-altering variants for precise pQTL mapping.
Presented by S. Batzoglou, Seer Inc.
Board No. PB1203 | Molecular Effects of Genetic Variation Poster Session III, 2:15pm – 4:15pm
To learn more about our technology, check out our multi-omics resources and see how researchers are getting richer and deeper access to the proteome and peptides in the free Proteomics Research Guide.
Want to meet with Seer at ASHG? Connect with our team below.
Stay connected with Seer while at @GeneticsSociety #ASHG23 via Twitter and LinkedIn.
